ESTRO 38 - Programme Book & Exhibition Guide

DEBATE This house believes that there is still a role for radiotherapy in pancreatic cancer 09:15 - 10:30 | Auditorium Overall pancreatic cancer has a very poor survival. To date, the sole curative treatment for non-metastasized pancreatic cancer is surgery. The role of radiation therapy in the management of pancreatic cancer has been subject of debate for decades. Recent results from clinical trials and the introduction of novel techniques such as SBRT may support the use of radiotherapy in the treatment of localized pancreatic cancer. However, systemic treatment options and other ablative therapies have evolved as well. The role of radiotherapy in both primary resectable and locally advanced pancreatic cancer will be debated in view of the latest insights. 09:15 > For the motion: resectable pancreatic cancer Speaker: T. Brunner (Germany) 09:30 > Against the motion: resectable pancreatic cancer Speaker: M. Falconi (Italy) 09:45 > For the motion: locally advanced pancreatic cancer Speaker: F. Huguet (France) 10:00 > Against the motion: locally advanced pancreatic cancer Speaker: E. Van Cutsem (Belgium) Chair: K. Haustermans (Belgium) Co-chair: M. Berbée (The Netherlands)

TUESDAY 30 APRIL 2019

SP-0656

SP-0657

SP-0658

SP-0659

10:15 > Discussion

SYMPOSIUM New developments in Head and Neck Cancer treatment 09:15 - 10:30 | Brown 3

Head and Neck oncology is being transformed by a series of major developments that relate to the epidemiology of the disease, the use of advanced forms of radiotherapy planning anddelivery, and the introduction of immunotherapy. In this session these three areas will be discussed by key experts. Dr. Lassen will discuss the impact of Human Papilloma Virus in oropharyngeal cancers, and will review the latest TNM staging. She will discuss how to optimally treat HPV positive OPC integrating an overview of the design and rationale of ongoing clinical trials and a presentation of lessons learned from completed clinical trials. Dr. Langendijk will present predictionmodels that and their integration in head and neck radiotherapy.

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

182